Triple
T22404543
| Position | Surface form | Disambiguated ID | Type / Status |
|---|---|---|---|
| Subject | Directive 2001/83/EC |
E553846
|
entity |
| Predicate | amendedBy |
P1121
|
FINISHED |
| Object |
Directive 2010/84/EU
Directive 2010/84/EU is a European Union legislative act that significantly strengthened and modernized the EU pharmacovigilance system to improve the monitoring and safety of medicinal products for human use.
|
E1533649
|
NE FINISHED |
How this triple was built (4 steps)
Every LLM step that produced this triple, in pipeline order — named-entity classification, the disambiguation choices (the exact options shown, with the pick highlighted), and the generated description. The batch + timestamp of each is in the Provenance table below.
NER
Named-entity recognition
gpt-5-mini
Instruction
Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).
Input
Phrase: Directive 2010/84/EU | Statement: [Directive 2001/83/EC, amendedBy, Directive 2010/84/EU]
NED1
Entity disambiguation (via context triple)
gpt-5-mini-2025-08-07
Target entity: Directive 2010/84/EU Context triple: [Directive 2001/83/EC, amendedBy, Directive 2010/84/EU]
-
A.
Directive 2010/53/EU
Directive 2010/53/EU is a European Union law that sets common standards for the quality and safety of human organs intended for transplantation across EU member states.
-
B.
Directive 2006/86/EC
Directive 2006/86/EC is a European Union legal act that sets detailed technical requirements for the traceability, notification of serious adverse reactions and events, and quality and safety standards for human tissues and cells used in medical treatments.
-
C.
Directive 2014/65/EU
Directive 2014/65/EU is a key European Union legislative act that overhauls and strengthens the regulatory framework for investment services and financial markets, commonly known as MiFID II.
-
D.
Directive 2001/83/EC
Directive 2001/83/EC is a key European Union law that sets the framework for the authorization, manufacture, distribution, and pharmacovigilance of medicinal products for human use across EU member states.
-
E.
Directive 2013/37/EU
Directive 2013/37/EU is a European Union law that updated and expanded the rules on the re-use of public sector information to promote transparency, innovation, and economic activity across the EU.
- F. None of above. chosen
- G. Unsure - the case is ambiguous/there is not enough information to decide.
NEDg
Description generation
gpt-5.1
Instruction
Generate a one-sentence description of the target entity. You are given a context triple in the form (subject, predicate, object), where the object is the target entity. # Instructions Use the triple to infer relevant information about the entity. Describe the entity based on what is most defining, well-known. Avoid repeating the information from the triple, unless really essential. # Response Format Return only the sentence: "Description: [one-sentence description of the target entity]"
Input
Entity: Directive 2010/84/EU Triple: [Directive 2001/83/EC, amendedBy, Directive 2010/84/EU]
Generated description
Directive 2010/84/EU is a European Union legislative act that significantly strengthened and modernized the EU pharmacovigilance system to improve the monitoring and safety of medicinal products for human use.
NED2
Entity disambiguation (via description)
gpt-5-mini-2025-08-07
Target entity: Directive 2010/84/EU Target entity description: Directive 2010/84/EU is a European Union legislative act that significantly strengthened and modernized the EU pharmacovigilance system to improve the monitoring and safety of medicinal products for human use.
-
A.
Directive 2010/53/EU
Directive 2010/53/EU is a European Union law that sets common standards for the quality and safety of human organs intended for transplantation across EU member states.
-
B.
Directive 2006/86/EC
Directive 2006/86/EC is a European Union legal act that sets detailed technical requirements for the traceability, notification of serious adverse reactions and events, and quality and safety standards for human tissues and cells used in medical treatments.
-
C.
Directive 2014/65/EU
Directive 2014/65/EU is a key European Union legislative act that overhauls and strengthens the regulatory framework for investment services and financial markets, commonly known as MiFID II.
-
D.
Directive 2001/83/EC
Directive 2001/83/EC is a key European Union law that sets the framework for the authorization, manufacture, distribution, and pharmacovigilance of medicinal products for human use across EU member states.
-
E.
Directive 2013/37/EU
Directive 2013/37/EU is a European Union law that updated and expanded the rules on the re-use of public sector information to promote transparency, innovation, and economic activity across the EU.
- F. None of above. chosen
Provenance (5 batches)
The batch behind each pipeline step, in order, with when it ran. Timestamps are batch-level — stages were processed in waves, so the object chain (NER → NED1 → NEDg → NED2) reads in order, but predicate / elicitation batches can sit in a different wave.
| Step | Stage | Batch ID | Status | When |
|---|---|---|---|---|
| creating | Elicitation | batch_69e11e4da7048190b4387d422a9a0de5 |
completed | April 16, 2026, 5:37 p.m. |
| NER | Named-entity recognition | batch_69f158b6762c8190991fc14c5ca8e609 |
completed | April 29, 2026, 1:02 a.m. |
| NED1 | Entity disambiguation (via context triple) | batch_6a0ae9cfabe081908d6a001bcfe5372c |
completed | May 18, 2026, 10:28 a.m. |
| NEDg | Description generation | batch_6a0aea5eef848190893c8b7f6066092d |
completed | May 18, 2026, 10:30 a.m. |
| NED2 | Entity disambiguation (via description) | batch_6a0aeaf55efc81909438a39cbfd5e723 |
completed | May 18, 2026, 10:33 a.m. |
Created at: April 16, 2026, 8:46 p.m.